Rui Avelar

2021

In 2021, Rui Avelar earned a total compensation of $1.2M as Chief Medical Officer and Head of Research and Development at Evolus.

Compensation breakdown

Non-Equity Incentive Plan$207,390
Salary$445,000
Stock Awards$582,300
Other$7,687
Total$1,242,377

Avelar received $582.3K in stock awards, accounting for 47% of the total pay in 2021.

Avelar also received $207.4K in non-equity incentive plan, $445K in salary and $7.7K in other compensation.

Rankings

In 2021, Rui Avelar's compensation ranked 7,989th out of 12,406 executives tracked by ExecPay. In other words, Avelar earned more than 35.6% of executives.

ClassificationRankingPercentile
All
7,989
out of 12,406
36th
Division
Manufacturing
3,528
out of 5,492
36th
Major group
Chemicals And Allied Products
1,567
out of 2,368
34th
Industry group
Drugs
1,392
out of 2,089
33rd
Industry
Pharmaceutical Preparations
1,031
out of 1,536
33rd
Source: SEC filing on May 8, 2023.

Avelar's colleagues

We found two more compensation records of executives who worked with Rui Avelar at Evolus in 2021.

2021

David Moatazedi

Evolus

Chief Executive Officer

2021

Lauren Silvernail

Evolus

Chief Financial Officer

News

You may also like